相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

瘤微环境中的铁:机制,进展和治疗前景

Weijuan Gao¹, Jiani Tan¹, Chengtao Yu¹

¹The First Clinical School of Nanjing University of Chinese Medicine, Nanjing, China.

Frontiers in oncology

|September 8, 2025

概括

细胞死亡过程铁亡是抑制瘤的关键,但可以影响瘤微环境. 了解其相互作用对于有效的癌症疗法至关重要.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
在瘤学瘤学.

背景情况:

铁亡是依赖铁的细胞死亡,涉及脂质过氧化物.
它充当瘤抑制剂,但影响瘤的进展和治疗耐药性.

研究的目的:

审查铁灭的机制及其与瘤微环境 (TME) 的相互作用.
讨论基于ferroptosis的癌症治疗的治疗潜力和挑战.

主要方法:

关于铁亡研究近期进展的文献综述.
对瘤进展,转移和治疗耐药性中的铁亡作用的分析.
检查铁亡与TME组件 (免疫,层状,内皮细胞) 的相互作用.

主要成果:

铁灭症在不同的TME细胞群体中表现出不同的敏感性.
铁和TME组件之间的相互作用显著重塑TME.
由于TME的变化,可能会产生诸如炎症和毒性等意外影响.

结论:

基于铁灭的疗法有希望,但需要仔细考虑TME效应.
需要进一步的研究,以优化ferroptosis诱导,同时管理TME相互作用,以获得更安全,更有效的癌症治疗.

关键词:

抗氧化剂抗氧化剂是一种抗氧化剂.铁性化 (ferroptosis) 是一种铁是铁,铁是铁,铁是铁.脂类过氧化物脂类过氧化物瘤微环境是一个微环境.

更多相关视频

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...